Day: May 2, 2022

NORWOOD, Mass., May 02, 2022 (GLOBE NEWSWIRE) — MariMed, Inc. (OTCQX: MRMD) (“MariMed” or the “Company”), a leading multi-state cannabis operator focused on improving lives every day, today announced its participation in the following upcoming conferences:Canaccord Genuity Virtual Cannabis Conference:   Senior Management will host one-on-one investor meetings on May 11th at Canaccord’s Virtual Cannabis Conference.Wolfe Research Virtual Consumer Conference: Senior management will participate in a fireside chat moderated by Wolfe Research Cannabis Analyst, Spencer Hanus on May 13th. Company management will also host one-on-one investor meetings.Jefferies Cannabis Summit: Senior management will participate in a fireside chat with the Jefferies Cannabis Analyst, Owen Bennett, in New York, NY, on June 2nd Company management will...

JOHNS CREEK, Ga., May 02, 2022 (GLOBE NEWSWIRE) — Saia, Inc. (Nasdaq: SAIA), a leading transportation provider offering national less-than-truckload (LTL), non-asset truckload, expedited and logistics services, today reported first quarter 2022 financial results.   Diluted earnings per share in the quarter were $2.98 compared to $1.40 in the first quarter of 2021.   Highlights from the first quarter operating results were as follows: First Quarter 2022 Compared to First Quarter 2021 ResultsRevenue was $661.2 million, a 36.6% increase Operating income was $103.4 million, a 112.4% increase Operating ratio of 84.4 compared to 89.9 LTL shipments per workday increased 5.7% LTL tonnage per workday increased 9.5% LTL revenue per hundredweight increased 21.4% LTL revenue per shipment rose 25.7% to $329.30“First quarter results include...

Data highlight proprietary allogeneic cell engineering platform capable of creating immune-evading T cells and deployable for TCR-T and CAR-T cell therapy Findings support recent development candidate initiation of NTLA-6001, an investigational allogeneic CAR-T therapy, for the treatment of CD30-expressing hematologic cancersCAMBRIDGE, Mass., May 02, 2022 (GLOBE NEWSWIRE) — Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading genome editing company focused on developing potentially curative therapies leveraging CRISPR-based technologies, today announced the presentation of new preclinical data from its differentiated allogeneic cell engineering platform at Keystone Symposia’s Precision Genome Engineering Conference, taking place April 27 – May 1, 2022, in Keystone, Colorado. The data presented support the development of NTLA-6001,...

FAIR LAWN, N.J., May 02, 2022 (GLOBE NEWSWIRE) — Columbia Bank MHC, Columbia Financial, Inc. (NASDAQ: CLBK) and Columbia Bank (collectively, “Columbia”) announced today that Columbia has completed its acquisition of RSI Bancorp, M.H.C., RSI Bancorp, Inc. and RSI Bank (collectively, “RSI”), effective as of May 1, 2022. At the effective time of the merger, RSI Bank was merged with and into Columbia Bank and depositors of RSI Bank became depositors of Columbia Bank, with the same rights and privileges in Columbia Bank MHC as if their accounts had been established in Columbia Bank on the date established at RSI Bank. In addition, as part of the transaction, the Company issued 6,086,314 shares of its common stock to Columbia Bank MHC. In connection with the transaction, RSI Bank also made a $5.0 million charitable contribution to a...

SOUTH SAN FRANCISCO, May 02, 2022 (GLOBE NEWSWIRE) — Akero Therapeutics, Inc. (Nasdaq: AKRO), a clinical-stage company developing transformational treatments for patients with serious metabolic diseases marked by high unmet medical need, today announced that management will participate in the following investor conferences this month:BofA Securities 2022 Healthcare Conference: Fireside chat on Wednesday, May 11 at 8:40 a.m. PT. in Las Vegas, Nevada. H.C. Wainwright Annual Global Life Sciences Conference: Fireside chat available for on-demand viewing on Tuesday, May 24 at 7:00 a.m. ET.Webcasts of each Company presentation will be available through the investor relations section of the Company’s website at www.akerotx.com. Following the webcasts, archived replays will be available on the Company’s website. About Akero...

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR DISSEMINATION IN UNITED STATES CALGARY, Alberta, May 02, 2022 (GLOBE NEWSWIRE) — Pieridae Energy Limited (“Pieridae” or the “Company”) (PEA.TO) will release its first quarter 2022 results on Thursday, May 12, 2022 prior to markets opening. Chief Executive Officer Alfred Sorensen, President and Chief Operating Officer Darcy Reding and Chief Financial Officer Adam Gray will discuss the financial results, Company developments and forward-looking strategy at 8:30 a.m. (MDT) /10:30 a.m. (EDT). Members of the investment community, shareholders and other interested parties are invited to participate by calling toll-free 1-877-800-8195, or international dial in 1-615-622-8082. Please dial in 10 minutes prior to the start of the call. No pass code is required. A live webcast of...

LEXINGTON, Mass., May 02, 2022 (GLOBE NEWSWIRE) — iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), a global, online marketplace that connects scientists in need of biospecimens for medical research with a network of healthcare providers who have them, today announced that it will report its financial results for the first quarter ended March 31, 2022, before the markets open on Tuesday, May 10, 2022. The Company will host a conference call and audio webcast that morning at 8:30 a.m. Eastern Time featuring remarks by Christopher Ianelli, MD, PhD, CEO and President, Tracy Curley, CFO and Treasurer, and Jill Mullan, COO and Secretary.Event: iSpecimen First Quarter 2022 Results Conference CallDate: Tuesday, May 10, 2022Time: 8:30 a.m. Eastern TimeLive Call: +1-800-954-0654 (U.S. Toll Free) or +1-212-231-2933...